Back

Calcium channel blockers in hypertensive heart failure: mortality outcomes and subgroup analysis

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Critical heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Viana Copeland

Chaim Sheba Medical Center, Tel Aviv Universty, Ramat Gan (Israel)

4 More presentations in this session

Presentation thumbnail
Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm
Associate Professor S. Lakhal-Littleton (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Clinical features and treatment strategies of cardiogenic shock in patients eligible for heart transplantation and mechanical circulatory support
Doctor S. Laterza (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
HIV impacts in-hospital mortality, resource utilization, and need for intubation in patients admitted due to heart failure exacerbation
Doctor L. Villarrubia Varela (New York, US)
Abstract Slides Video
Presentation thumbnail
The independent factors associated with myocardial extracellular volume fraction in acute decompensated heart failure patients
Doctor T. Xu (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Critical heart failure

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between calcium channel blockers prescription and outcome according to left ventricular ejection fraction: data from a real-world heart failure population
thumbnail
Congress Session
Personalised therapy in heart failure
thumbnail
Congress Session
Advances in heart failure detection and therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources